Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group StudyC. Lhommé, S. Pecorelli, Jan B. Vermorken et al.|European Journal of Cancer|2000Cited by 43
Up-Front Treatment of Diffuse Large-B Cell Lymphoma (DLBCL) in Elderly Patients with Rituximab in Combination with CHOP-Like Chemotherapy: A Multicenter Study on the Current Clinical Management.Miguel Canales, F. Hernández‐Navarro, Raquel Gil et al.|Blood|2005Cited by 1
In spite of enhancing the complete response (CR) rate with more cycles of neoadjuvant chemotherapy (NACT) only an early complete response (ECR) correlates with a better disease free survival (DFS) for larynx preservation (LP)R. Giglio, Pablo Menéndez, R Pradier et al.|Journal of Clinical Oncology|2004Cited by 0
In spite of enhancing the complete response (CR) rate with more cycles of neoadjuvant chemotherapy (NACT) only an early complete response (ECR) correlates with a better disease free survival (DFS) for larynx preservation (LP)R. Giglio, Pablo Menéndez, Ana Alvarez et al.|Journal of Clinical Oncology|2004Cited by 0